Results 41 to 50 of about 347 (132)

Behavior of Anemia due to Toxicity to Chemotherapy in Patients with Lung Cancer

open access: yesRevista Finlay, 2023
Foundation: anemia constitutes one of the most frequent toxicities with intrinsic risk factors in the patient. Anemia due to toxicity due to chemotherapy is considered a single-line hematopoietic dysfunction of iatrogenic cause due to its relationship to
Mahité Cañete Fonseca   +2 more
doaj  

Clinical and economic aspects of the use of rituximab in non-Hodgkin's lymphoma

open access: yesBrazilian Journal of Pharmaceutical Sciences, 2014
Non-Hodgkin's lymphoma (NHL) consists of a group of neoplasias involving mainly B cells and represents 90% of all lymphomas. The current available therapy is based on chemotherapy associated with the monoclonal antibody rituximab (Mab Thera(r)), which ...
Camila Bezerra Melo Figueirêdo   +4 more
doaj   +1 more source

Primary lymphoma of bone, a case report

open access: yesActa Médica del Centro, 2014
It is presented the clinical case of a patient  with a diagnosis of primary lymphoma of bone-a clinicopathologic rare disease that accounts for less than 1% of all lymphomas and 3 to 4% of primary bone tumors and it is defined as that in which a bone ...
Eduardo Ibáñez Carrillo   +2 more
doaj  

Cirugía del salvación del miembro en el tratamiento de osteosarcoma de peroné con supervivencia a los diecisiete años.

open access: yesRevista de la Facultad de Ciencias Médicas de Córdoba, 2019
Introducción: El osteosarcoma es el tumor óseo primario más frecuente habiendo dos picos de incidencia, uno en torno a los 15 años (adolescentes) y otro en ancianos. Caso clínico: Paciente de 14 años con clínica de dolor en región proximal de peroné.
Ruth Lumbreras   +4 more
doaj  

Terapias combinadas contra tumores murinos : inmunoterapia y quimioterapia. Relación de la eficacia del tratamiento con el estado inmunológico del portador

open access: yes, 2011
Tumor-draining lymph nodes (TDLN) are central sites where T cell priming to tumor antigens and onset of the antitumor immune response occur. However, tumor-induced immunosuppression has been demonstrated at TDLN, leading to downregulation of antitumor reaction and tolerance induction. Tolerance in turn is a main impairment for immunotherapy trials.
openaire   +3 more sources

Linfoma de células T del adulto asociado a HTLV-1

open access: yesRevista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica, 2017
El linfoma de células T del adulto es una neoplasia maligna de linfocitos T periféricos causada por el HTLV-1 (Human T-cell Lymphotropic Virus, type 1), endémico en Colombia.
Lucía Giraldo   +3 more
doaj   +1 more source

Rol de la quimioterapia en el cáncer gástrico avanzado

open access: yesOncología, 2021
Presentamos el caso de un paciente masculino, 50 años de edad, sometido a gastrectomía total más linfadenectomía D2 por un Adenocarcinoma gástrico y que recibió tratamiento adyuvante con quimioterapia y radioterapia.
Jaime Sánchez S.   +2 more
doaj  

Caso Clínico: Tumor de Askin

open access: yesOncología, 2017
Introducción: El tumor neuroectodérmico primitivo (PNET) de la pared torácica también denominado tumor de  Askin es una neoplasia rara y agresiva, que afecta mayoritariamente a niños y adolescente.
Hollwuin Alfredo Solórzano Morales
doaj   +1 more source

Redox Status in Patients with non-small Cell Lung Cancer in Advanced Stages Treated with Polychemotherapy

open access: yesRevista Finlay, 2022
Background: in advanced stages of non-small cell lung cancer, treatment is fundamentally based on polychemotherapy. Previous studies relate the development of resistance to cisplatin with increased levels of cellular glutathione, while depletion of this ...
Gretel Riverón Forment   +4 more
doaj  

Home - About - Disclaimer - Privacy